Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

1,562 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation and management of a patient with chronic pruritus.
Steinhoff M, Cevikbas F, Yeh I, Chong K, Buddenkotte J, Ikoma A. Steinhoff M, et al. Among authors: chong k. J Allergy Clin Immunol. 2012 Oct;130(4):1015-6.e7. doi: 10.1016/j.jaci.2012.08.006. J Allergy Clin Immunol. 2012. PMID: 23021147 No abstract available.
Cutting edge in medical management of cutaneous oncology.
Chong K, Daud A, Ortiz-Urda S, Arron ST; UCSF High Risk Skin Cancer Program. Chong K, et al. Semin Cutan Med Surg. 2012 Jun;31(2):140-9. doi: 10.1016/j.sder.2012.03.002. Semin Cutan Med Surg. 2012. PMID: 22640435 Free PMC article. Review.
Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo.
Posch C, Moslehi H, Feeney L, Green GA, Ebaee A, Feichtenschlager V, Chong K, Peng L, Dimon MT, Phillips T, Daud AI, McCalmont TH, LeBoit PE, Ortiz-Urda S. Posch C, et al. Among authors: chong k. Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4015-20. doi: 10.1073/pnas.1216013110. Epub 2013 Feb 19. Proc Natl Acad Sci U S A. 2013. PMID: 23431193 Free PMC article.
The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II clinical trial.
Algazi AP, Cha E, Ortiz-Urda SM, McCalmont T, Bastian BC, Hwang J, Pampaloni MH, Behr S, Chong K, Cortez B, Quiroz A, Coakley F, Liu S, Daud AI. Algazi AP, et al. Among authors: chong k. Br J Cancer. 2015 Apr 14;112(8):1326-31. doi: 10.1038/bjc.2014.541. Epub 2015 Mar 31. Br J Cancer. 2015. PMID: 25867272 Free PMC article. Clinical Trial.
Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma.
Sanlorenzo M, Choudhry A, Vujic I, Posch C, Chong K, Johnston K, Meier M, Osella-Abate S, Quaglino P, Daud A, Algazi A, Rappersberger K, Ortiz-Urda S. Sanlorenzo M, et al. Among authors: chong k. J Am Acad Dermatol. 2014 Dec;71(6):1102-1109.e1. doi: 10.1016/j.jaad.2014.09.002. Epub 2014 Oct 16. J Am Acad Dermatol. 2014. PMID: 25440439 Free PMC article.
Patterns of Treatment and Real-World Outcomes of Patients With Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations Receiving Mobocertinib: The EXTRACT Study.
Liu G, Nyaw SF, Mok TSK, Curcio H, Cortot AB, Kam TY, Descourt R, Chik YK, Cheema P, Gwinnutt JM, Churchill EN, Nyborn J, Curran E, Savell A, Yin Y, Chong K, Tanaka-Chambers Y, Kretz J, Cadranel J. Liu G, et al. Among authors: chong k. Cancer Med. 2025 Feb;14(3):e70369. doi: 10.1002/cam4.70369. Cancer Med. 2025. PMID: 39861957 Free PMC article.
1,562 results